K201606 is an FDA 510(k) clearance for the LacriJet®. Classified as Lacrimal Stents And Intubation Sets (product code OKS).
Submitted by Fci (France Chirurgie Instrumentation) Sas (Paris, FR). The FDA issued a Cleared decision on December 18, 2020 after a review of 186 days - an extended review cycle.
This device falls under the Ophthalmic FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.
View all Fci (France Chirurgie Instrumentation) Sas devices